Announced plans for new, state-of-the-art cell therapy R&D facility in Philadelphia Cash and cash equivalents ... These expenses are primarily due to research and development activities in cilta-cel, ...
The Phase III trial AV001 aims to evaluate QUTENZA® in post- surgical neuropathic pain (PSNP), a debilitating complication of surgery occurring after ...